Missed GME or NVDA? Don’t Miss the Next One.​
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
IINN Stock Forecast 2025-2026
$0.50
Current Price
$12.78M
Market Cap
Buy 0
Hold 0
Sell 0
Wall St Analyst Ratings
Distance to IINN Price Targets
N/A
To High Target of $N/A
N/A
To Median Target of $N/A
N/A
To Low Target of $N/A
IINN Price Momentum
-2.0%
1 Week Change
-16.7%
1 Month Change
-76.6%
1 Year Change
-51.0%
Year-to-Date Change
-79.1%
From 52W High of $2.39
+7.1%
From 52W Low of $0.47
📉 MARKET SELLOFF ALERT
10 Quality Stocks Worth Considering Now
Researching Inspira Technologies (IINN) after the drop? Our ex-Goldman Sachs analyst reveals if it made our list of 10 oversold quality stocks with strong growth potential.
Get our FREE market selloff report + exclusive analysis on IINN and similar high-potential opportunities.
Latest IINN Stock Price Targets & Analyst Predictions
IINN has shown a year-to-date change of -51.0% and a 1-year change of -76.6%, reflecting downward momentum over the past year. Comprehensive analyst forecasts are currently unavailable for IINN. Please refer to the price chart above for recent performance and trends.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
IINN Analyst Ratings
0
Buy
0
Hold
0
Sell
IINN Price Target Range
Low
N/A
Average
N/A
High
N/A
Current: $0.50
Latest IINN Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for IINN.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Jan 25, 2023 | Aegis Capital | David Bouchey | Buy | Maintains | $13.00 |
| Dec 31, 2021 | Aegis Capital | Buy | Maintains | $0.00 | |
| Nov 1, 2021 | Aegis Capital | Nathan Weinstein | Buy | Maintains | $10.00 |
| Aug 26, 2021 | Aegis Capital | Buy | Initiates | $0.00 |
Inspira Technologies Oxy B.H.N. Ltd. (IINN) Competitors
The following stocks are similar to Inspira Technologies based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
IINN
Inspira Technologies
mkt cap
13.20M
Inspira Technologies Oxy B.H.N. Ltd. (IINN) Financial Data
Inspira Technologies Oxy B.H.N. Ltd. has a market capitalization of $12.78M with a P/E ratio of 0.0x. The company generates $0 in trailing twelve-month revenue with a 0.0% profit margin.
Revenue growth is N/A quarter-over-quarter, while maintaining an operating margin of 0.0% and return on equity of -219.7%.
Valuation Metrics
Market Cap
$12.78M
Enterprise Value
$6.25M
P/E Ratio
0.0x
PEG Ratio
-0.7x
Price/Sales
0.0x
Growth & Margins
Revenue Growth (YoY)
N/A
Gross Margin
N/A
Operating Margin
0.0%
Net Margin
0.0%
EPS Growth
N/A
Financial Health
Cash/Price Ratio
+57.5%
Current Ratio
2.0x
Debt/Equity
15.3x
ROE
-219.7%
ROA
-81.0%
💰 DON'T MISS THIS OPPORTUNITY
Get All 10 Quality Stocks For This Market Selloff
Still researching investments after the market drop? Our ex-Goldman Sachs analyst has already identified the 10 highest-quality oversold stocks with strong fundamentals and upside potential.
Why spend hours researching when we've already done the work? Get instant access to our complete market selloff analysis.
Inspira Technologies Oxy B.H.N. Ltd. (IINN) Business Model
About Inspira Technologies Oxy B.H.N. Ltd.
What They Do
Develops innovative respiratory support solutions.
Business Model
The company focuses on creating advanced medical devices for respiratory support, primarily targeting hospitals and emergency facilities. Its main revenue stream is generated from the sales of its minimally invasive blood oxygenation device, which offers advantages over traditional mechanical ventilation.
Additional Information
Inspira Technologies is positioned in a significant market due to the rising demand for effective treatments for acute respiratory failure. The company's technology aims to improve patient mobility and comfort, potentially transforming standards of care in respiratory health.
Company Information
Sector
Healthcare
Industry
Medical Devices
Employees
37
CEO
Mr. Dagi Shahar Ben-Noon
Country
Israel
IPO Year
2021
Website
inspira-technologies.comInspira Technologies Oxy B.H.N. Ltd. (IINN) Latest News & Analysis
Latest News
INSPIRA ART100 System Approved by Israel's Largest Healthcare Provider for Use in Organ Transplant Patients
16 days ago
Quick Summary
Inspira Technologies (NASDAQ: IINN) announced FDA-approved INSPIRA ART100 will undergo clinical validation by physicians at Israel's largest healthcare provider for organ transplant procedures.
Why It Matters
Inspira's approval for clinical validation of its ART100 device by a major healthcare provider signals potential market expansion and revenue growth, boosting investor confidence in its future prospects.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Inspira Achieves above 99% Gas Exchange Efficiency in VORTXâ„¢ Technology In-Vivo Animal Testing
1 month ago
Quick Summary
Inspira Technologies (Nasdaq: IINN, IINNW) has announced a significant milestone in in-vivo testing for its next-generation VORTXâ„¢ technology as of April 23, 2025.
Why It Matters
Inspira's announcement of successful in-vivo testing for its VORTXâ„¢ technology could indicate potential advancements in medical technology, impacting future revenue and market position.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Quick Summary
The Company reports initial revenues from FDA-cleared life support technology in a U.S. healthcare facility, with plans for additional systems in a second hospital.
Why It Matters
Initial revenue from FDA-cleared life support technology indicates market validation and growth potential, enhancing the company's financial outlook and attractiveness to investors.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Quick Summary
Inspira Technologies (NASDAQ: IINN) has begun deploying its FDA-cleared INSPIRA ART100 system at a top-ranked New York cardiothoracic program, marking a key commercialization milestone amid active medtech M&A.
Why It Matters
Inspira Technologies' FDA clearance and deployment of its system at a top-ranked facility signals growth potential, enhancing investor interest amid robust M&A activity in the medtech sector.
Source: Business Wire
Market Sentiment:
Neutral
Inspira Technologies Announces Successful Installation of INSPIRA ART100 Systems in Premier U.S. Hospital
1 month ago
Quick Summary
Inspira Technologies (NASDAQ: IINN) announced successful deployment of its FDA-cleared INSPIRAâ„¢ ART100 system for cardiopulmonary bypass at a major New York hospital.
Why It Matters
Successful deployment of the INSPIRA ART100 system at a leading U.S. hospital enhances credibility, potentially boosts sales, and reflects growth in the medical technology sector for Inspira.
Source: PRNewsWire
Market Sentiment:
Neutral
Quick Summary
Inspira Technologies (Nasdaq: IINN) will showcase its FDA-cleared INSPIRAâ„¢ ART100 life-support system at the AmSECT conference in San Diego from March 19-23, 2025, through distributor Glo-Med.
Why It Matters
Inspira's FDA-cleared INSPIRAâ„¢ ART100 technology will be showcased at a major industry event, highlighting its innovation and potential market interest, which could drive investor confidence and stock performance.
Source: PRNewsWire
Market Sentiment:
Neutral
Frequently Asked Questions About IINN Stock
What is Inspira Technologies Oxy B.H.N. Ltd.'s (IINN) stock forecast for 2025?
Analyst forecasts for Inspira Technologies Oxy B.H.N. Ltd. (IINN) are not currently available. The stock is trading at $0.50.
Is IINN stock a good investment in 2025?
Analyst ratings for IINN are not currently available. The stock is currently trading at $0.50. Investment decisions should be based on thorough research and your personal financial goals. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for IINN stock?
Price predictions from Wall Street analysts for IINN are not currently available. The stock is trading at $0.50.
What is Inspira Technologies Oxy B.H.N. Ltd.'s business model?
The company focuses on creating advanced medical devices for respiratory support, primarily targeting hospitals and emergency facilities. Its main revenue stream is generated from the sales of its minimally invasive blood oxygenation device, which offers advantages over traditional mechanical ventilation.
What is the highest forecasted price for IINN Inspira Technologies Oxy B.H.N. Ltd.?
Price targets from Wall Street analysts for IINN are not currently available. The stock is trading at $0.50.
What is the lowest forecasted price for IINN Inspira Technologies Oxy B.H.N. Ltd.?
Price targets from Wall Street analysts for IINN are not currently available. The stock is trading at $0.50.
What is the overall IINN consensus from analysts for Inspira Technologies Oxy B.H.N. Ltd.?
Analyst ratings for IINN are not currently available. The stock is trading at $0.50.
How accurate are IINN stock price projections?
Stock price projections, including those for Inspira Technologies Oxy B.H.N. Ltd., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: May 23, 2025 5:14 PM UTC